Molecular Formula | C15H14N4O3 |
Molar Mass | 298.3 |
Density | 1.55±0.1 g/cm3(Predicted) |
Melting Point | >270°C (dec.) |
Boling Point | 609.183°C at 760 mmHg |
Flash Point | 322.223°C |
Solubility | DMSO (Slightly), Methanol (Slightly, Heated) |
Vapor Presure | 0mmHg at 25°C |
Appearance | Pale pink solid |
Color | White to Pale Pink |
pKa | 4.30±0.10(Predicted) |
Storage Condition | Keep in dark place,Inert atmosphere,Room temperature |
Refractive Index | 1.746 |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. |
HS Code | 29335990 |
Introduction | 4-[2-(2-amino -4, 7-dihydro-4-oxo-3H-pyrrolo [2,3] pyrimidine-5-yl) ethyl] benzoic acid has a boiling point of 609.2±65.0 degrees (at one atmosphere) and a density of 1.6, the appearance is white or gray-blue solid powder under normal temperature and pressure. It can be used as a pharmaceutical intermediate. It has a certain solubility in dimethyl sulfoxide and methanol, but it has poor solubility in water. |
synthesis method | from its corresponding 2, 4-diamino-6-hydroxypyrimidine and the corresponding 2-bromoaldehyde under certain conditions Dehydrated condensation to obtain 4-[2-(2-amino -4, 7-dihydro-4-oxo-1H-pyrrole [2,3-d] pyrimidin-5-yl) ethyl] benzoic acid methyl ester, the ester product obtained can be hydrolyzed into carboxylic acid under alkaline conditions to obtain 4-[2-(2-amino -4, 7-dihydro-4-oxo-3H-pyrrolo [2,3] pyrimidin-5-yl) ethyl] benzoic acid. |